Alternatives to Eximore

A global pharmaceutical company focused on developing and marketing innovative treatments.

Global biopharmaceutical company developing breakthrough treatments for ophthalmic and neuro-ophthalmic conditions.

Omnix Medical is developing a novel platform for advanced wound care management.

Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.

Biotech developing novel technologies to restore physiological balance in apoptosis-related diseases.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Biopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Develops a platform for adaptive clinical trial design and closed-loop execution.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

AI-powered insights platform for life sciences and biotech workflows.

Biotechnology company developing potentially curative cell therapies for cancer patients.

Biotech company developing next-generation immunotherapy agents to unlock the immune system.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Cloud-based platform for reproducible computational research in life sciences.

Omec.ai is a life sciences startup focused on accelerating drug discovery and development through AI.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Biomica is developing a novel microbiome-based platform for the treatment of cancer.

Developing novel therapeutic approaches for ocular diseases.

Developing novel suprachoroidal delivery technology for targeted, rapid, and durable retinal disease treatments.

Clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Develops and launches Padeliporfin VTP therapy for solid tumor treatment.

Drug discovery and development company using a novel technological approach.

Clinical-stage biotech developing novel therapeutics for hematological malignancies and disorders.

Pioneering vision restoration therapies for severe retinal degenerations.

Develops minimally invasive bioelectronic solutions for treating low back pain and spinal degeneration.

Develops a novel method to predict patient response to immune checkpoint inhibitors in oncology.

Develops and distributes bioreactor technology for stem cell cultivation.

AI-driven digital twin of embryo development for cell-based therapies.

Developing topical treatments to prevent and treat skin toxicities from cancer therapies.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Developing a novel therapeutic approach for neurological disorders using advanced neuroimaging and AI.

Developing universal donor-free red blood cells for life-saving transfusions and advanced therapies.

Biopharmaceutical startup developing novel therapies for rare genetic diseases.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Develops bacteria-based immunotherapy to enhance anti-tumor immunity for cancer treatment.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

AI-driven platform for protein-level disease mapping and drug discovery.

Biotechnology company developing novel therapies for multiple myeloma.

AI-powered blood test for early cancer detection and subtyping.

Own Chemex.ai today. Secure checkout and guided transfer support. No hidden fees.

Develops a platform for individual drug customization using aptamers for cancer treatment.

AI-powered epiproteomic analysis platform for mass spectrometry data.

Developing exosome-based cancer therapeutics using AI and novel human cancer models.

Compressing biology to develop the next generation of therapies.

Galimedix Therapeutics is a clinical-stage biopharmaceutical company developing novel radiopharmaceuticals for PET imaging.

Revolutionizing drug design using quantum computing, AI, and personalized medicine.

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.

Developing novel therapeutics targeting the tumor microenvironment for cancer treatment.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

AI platform for discovering complex multi-omics signatures for personalized medicine.

Develops autologous engineered tissue from omentum biopsies for medical conditions.

Genocure AI is developing AI-powered solutions for oncology drug discovery and development.

Synthetic biology startup optimizing gene expression for food and biotech applications.

Developing polymer-based nanoparticles for targeted gene therapy delivery.

Leveraging proteomics and machine learning for improved immunotherapy decisions and drug discovery.